Insider · CIK 0001206868

BULLOCK LAWRENCE E

Reports to the SEC for 2 companies · FRANKLIN, TN

sec.gov

Transactions

Companies

Filings

CIK

0001206868

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-08-03	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Chief Financial Officer	AAward	+4,168 sh	—	—	4,168
2016-09-19	APPLIED GENETIC TECHNOLOGIES CORPP Purchase	Chief Financial Officer	PPurchase	+10K sh	$8.75	+$87.5K	10,000
2016-07-07	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Chief Financial Officer	AAward	+35K sh	—	—	35,000
2015-07-21	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Chief Financial Officer	AAward	+37K sh	—	—	37,000
2014-07-31	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60.8K sh	—	—	60,799
2013-03-01	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−25K sh	—	—	0
2013-03-01	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−27K sh	—	—	0
2013-03-01	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−113K sh	—	—	0
2013-03-01	BIOMIMETIC THERAPEUTICS, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−21K sh	—	—	0
2013-03-01	BIOMIMETIC THERAPEUTICS, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−89.2K sh	—	—	0
2013-03-01	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−80K sh	—	—	0
2013-03-01	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−40K sh	—	—	0
2013-03-01	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−37.5K sh	—	—	0
2013-03-01	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−30K sh	—	—	0
2012-03-20	BIOMIMETIC THERAPEUTICS, INC.P Purchase	Chief Financial Officer	PPurchase	+17.7K sh	$2.20	+$38.9K	78,723
2012-03-19	BIOMIMETIC THERAPEUTICS, INC.P Purchase	Chief Financial Officer	PPurchase	+2,330 sh	$2.20	+$5,126	61,053
2012-02-29	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000
2011-10-11	BIOMIMETIC THERAPEUTICS, INC.G Gift	Chief Financial Officer	GGift	−16K sh	—	—	58,723
2011-10-11	BIOMIMETIC THERAPEUTICS, INC.G Gift	Chief Financial Officer	GGift	+16K sh	—	—	28,000
2011-01-19	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2010-12-03	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−37.5K sh	—	—	0
2010-12-03	BIOMIMETIC THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+37.5K sh	$3.63	+$136K	65,620
2010-02-03	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+37.5K sh	—	—	37,500
2010-01-07	BIOMIMETIC THERAPEUTICS, INC.G Gift	Chief Financial Officer	GGift	−4,000 sh	—	—	26,158
2010-01-07	BIOMIMETIC THERAPEUTICS, INC.G Gift	Chief Financial Officer	GGift	+4,000 sh	—	—	12,000
2009-07-28	BIOMIMETIC THERAPEUTICS, INC.G Gift	Chief Financial Officer	GGift	−4,000 sh	—	—	29,760
2009-07-28	BIOMIMETIC THERAPEUTICS, INC.G Gift	Chief Financial Officer	GGift	+4,000 sh	—	—	8,000
2009-04-01	BIOMIMETIC THERAPEUTICS, INC.P Purchase	Chief Financial Officer	PPurchase	+400 sh	$6.87	+$2,748	28,668
2009-04-01	BIOMIMETIC THERAPEUTICS, INC.P Purchase	Chief Financial Officer	PPurchase	+600 sh	$6.86	+$4,116	28,268
2009-04-01	BIOMIMETIC THERAPEUTICS, INC.P Purchase	Chief Financial Officer	PPurchase	+4,400 sh	$6.80	+$29.9K	27,668
2009-04-01	BIOMIMETIC THERAPEUTICS, INC.P Purchase	Chief Financial Officer	PPurchase	+200 sh	$6.75	+$1,350	23,268
2009-04-01	BIOMIMETIC THERAPEUTICS, INC.P Purchase	Chief Financial Officer	PPurchase	+200 sh	$6.73	+$1,346	23,068
2009-04-01	BIOMIMETIC THERAPEUTICS, INC.P Purchase	Chief Financial Officer	PPurchase	+200 sh	$6.72	+$1,344	22,868
2009-02-26	BIOMIMETIC THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2008-02-27	BIOMIMETIC THERAPEUTICS, INC.G Gift	Chief Financial Officer	GGift	−2,000 sh	—	—	22,668
2008-02-27	BIOMIMETIC THERAPEUTICS, INC.G Gift	Chief Financial Officer	GGift	+2,000 sh	—	—	4,000
2007-12-31	BIOMIMETIC THERAPEUTICS, INC.G Gift	Chief Financial Officer	GGift	+2,000 sh	—	—	2,000
2007-12-31	BIOMIMETIC THERAPEUTICS, INC.G Gift	Chief Financial Officer	GGift	−2,000 sh	—	—	12,135
2007-01-16	BIOMIMETIC THERAPEUTICS, INC.Stock OptionA Award	Chief Financial Officer	AAward	+27K sh	$12.59	+$340K	177,000

Recent filings

Accepted (ET)
Aug 94
BULLOCK LAWRENCE E0000899243-17-019998
SEC(opens sec.gov)
Sep 204
APPLIED GENETIC TECHNOLOGIES CORP0000899243-16-029442
SEC(opens sec.gov)
Jul 114
APPLIED GENETIC TECHNOLOGIES CORP0000899243-16-024893
SEC(opens sec.gov)
Jul 234
APPLIED GENETIC TECHNOLOGIES CORP0000899243-15-001579
SEC(opens sec.gov)
Aug 44
APPLIED GENETIC TECHNOLOGIES CORP0001209191-14-050387
SEC(opens sec.gov)
Mar 54
BIOMIMETIC THERAPEUTICS, INC.0001209191-13-014333
SEC(opens sec.gov)
Mar 214
BIOMIMETIC THERAPEUTICS, INC.0001209191-12-019338
SEC(opens sec.gov)
Mar 24
BIOMIMETIC THERAPEUTICS, INC.0001209191-12-015002
SEC(opens sec.gov)
Feb 134
BIOMIMETIC THERAPEUTICS, INC.0001209191-12-009606
SEC(opens sec.gov)
Jan 214
BIOMIMETIC THERAPEUTICS, INC.0001209191-11-004419
SEC(opens sec.gov)

Companies

Address

BIOMIMETIC THERAPEUTICS, INC. 389 NICHOL MILL LANE

FRANKLIN, TN, 37067